Try Fund Library Premium
For Free with a 30 day trial!
Sector: Real Estate
|
Close (12-12-2025) |
$53.21 |
|---|---|
| Change |
-$0.28
(-0.52%)
|
| Volume | 312,563 |
| Open | $53.54 |
|---|---|
| Day Range | $52.77 - $54.08 |
| 52 Week Low | $44.26 |
| 52 Week High | $90.34 |
| Annual Yield | 1.13% |
|---|---|
| Annual Dividend | $0.60 |
| Last Dividend (09-30-2025) | $0.15 |
| Industry Sector | Real Estate |
|---|---|
| Quoted Market Value | $2,477,960,222 |
| Shares Outstanding | 46,569,446 |
| Book Value per Share | $3.24 |
| Earnings per Share | $3.85 |
| Date | Close | Change |
|---|---|---|
| December 12, 2025 | 53.21 |
-$0.28
(-0.52%)
|
| December 11, 2025 | 53.49 |
$0.08
(0.15%)
|
| December 10, 2025 | 53.41 |
$1.76
(3.41%)
|
| December 09, 2025 | 51.65 |
$0.53
(1.04%)
|
| December 08, 2025 | 51.12 |
-$0.21
(-0.41%)
|
| December 05, 2025 | 51.33 |
-$0.01
(-0.02%)
|
| December 04, 2025 | 51.34 |
$0.45
(0.88%)
|
| December 03, 2025 | 50.89 |
$0.87
(1.74%)
|
| December 02, 2025 | 50.02 |
-$0.23
(-0.46%)
|
| December 01, 2025 | 50.25 |
$0.47
(0.94%)
|
| November 28, 2025 | 49.78 |
$0.70
(1.43%)
|
| November 27, 2025 | 49.08 |
$0.00
(0.00%)
|
| November 26, 2025 | 49.08 |
$0.73
(1.51%)
|
| November 25, 2025 | 48.35 |
$1.81
(3.89%)
|
| November 24, 2025 | 46.54 |
-$0.75
(-1.59%)
|
| November 21, 2025 | 47.29 |
$1.38
(3.01%)
|
| November 20, 2025 | 45.91 |
-$0.37
(-0.80%)
|
| November 19, 2025 | 46.28 |
$0.71
(1.56%)
|
| November 18, 2025 | 45.57 |
$0.43
(0.95%)
|
| November 17, 2025 | 45.14 |
$0.20
(0.45%)
|
| November 14, 2025 | 44.94 |
$0.03
(0.07%)
|
| November 13, 2025 | 44.91 |
-$1.64
(-3.52%)
|
| November 12, 2025 | 46.55 |
$0.26
(0.56%)
|
| November 11, 2025 | 46.29 |
-$0.60
(-1.28%)
|
| November 10, 2025 | 46.89 |
-$2.84
(-5.71%)
|
| November 07, 2025 | 49.73 |
-$2.71
(-5.17%)
|
| November 06, 2025 | 52.44 |
-$3.56
(-6.36%)
|
| November 05, 2025 | 56.00 |
-$1.37
(-2.39%)
|
| November 04, 2025 | 57.37 |
-$1.29
(-2.20%)
|
| November 03, 2025 | 58.66 |
-$0.97
(-1.63%)
|
Try Fund Library Premium
For Free with a 30 day trial!